Some very good points havasu78. Thanks for sharin
Post# of 145707
This one in particular I had not considered:
Quote:Regarding this comment:
1) Mexico protocol permits combining 25 Mexico patients with the 50 interim patients from the US phase 2/3 severe/critical trial
Quote:I'd would just like to say the 25 subject trial was discussed way back at the very beginning of the Mexico trail announcement. As such, I don't view it as a product of any recent event, such as CytoDyn's potential understanding of the US P3 S/C results.
At any rate, I think the main point is just what you said: they picked 25 for Mexico cuz they knew the US results, perhaps even they knew the intirety of the US results yesterday when the finalized Mexico.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)